Abiopharma

News list

Tse Alan K 🟡 adjusted position in 2.4K shares of JONES LANG LASALLE INC (JLL) at $297.00 Transaction Date: Mar 31, 2026 | Filing ID: 000057

Full text

News bot April 2, 2026, 5:02 p.m.
🔍 Tse Alan K (Executive)

Company: JONES LANG LASALLE INC (JLL)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 4,296
- Total shares sold: 1,904
Detailed Transactions and Holdings:
- Acquired 4,296 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,009.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 1,904 shares of Common Stock at $297.0 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 18,105.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents shares of the Issuer's common stock issued upon the vesting of performance share units granted on April 5, 2023.
- F2: Represents the number of shares of the Issuer's common stock withheld for payment of taxes upon the vesting of performance share units, and the conversion of such units into shares of the Issuer's common stock, granted on April 5, 2023.